THE COMPATIBILITY OF NEUTROPHIL TO LYMPHOCYTE COUNT RATIO WITH SERUM PROCALCITONIN AS BACTERIAL INFECTION MARKERS IN SEPSIS PATIENTS
DOI:
https://doi.org/10.24293/ijcpml.v25i1.1492Keywords:
Ratio neutrophil lymphocyte, procalcitonin, sepsisAbstract
Bacterial infections and sepsis remain significant causes of morbidity and mortality in critical cases in Intensive Care Units (ICU) around the world. A quick and accurate diagnosis for sepsis is a challenge for clinicians and laboratory. The problem of an existing marker for sepsis with high sensitivity and specificity is still not satisfactory. Serum procalcitonin test is still widely used but cannot be supported by hospital laboratories especially in the regional public hospitals and needs more cost. Neutrophil-lymphocyte ratio is a potential index, easy, fast and cheap for bacteremia in patients with sepsis. This study aimed to determine the agreement of neutrophil-lymphocyte ratio with serum procalcitonin as a bacterial infection marker in sepsis patients. This study was an observational, analytical study with a cross-sectional design of 30 patients who had been diagnosed as sepsis by clinicians based on clinical signs of sepsis in the Intensive Care Unit of the Dr. M. Djamil Hospital Padang. The study was conducted from February to July 2016. Neutrophil and lymphocyte count was performed by flow cytometry method and procalcitonin test with Enzyme Linked Fluorescent Assay (ELFA). Results were analyzed by Kappa test with a statistical significance if p < 0.05. There were 30 subjects, consisting of 15 females (50%) and 15 males (50%) with the age mean of 48 years. Based on the Kappa test, the value obtained was kappa=0.634 (p=0.001) for the ratio neutrophil lymphocyte with procalcitonin. There was a substantial agreement between ratio neutrophil lymphocyte with procalcitonin test.Downloads
References
Chen K, Pohan HT. Penatalaksanaan syok septik. In: Buku ajar ilmu penyakit dalam, 5th Ed., Ed. Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata KM, Setiati S, Jakarta Pusat, Internal Publishing, 2009; 252-55.
Suharto. Sepsis dasar patogenesis dan pemberian obat antimikroba. In: Penyakit infeksi di Indonesia. Ed. Nasronudin, Hadi U, Vitanata, Bramantono EAT, Suharto, Soewandojo E. Surabaya, Airlangga University Press, 2007; 246-55.
Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: A prospective study. Crit Care, 2007; 11(2): 1-10.
CDC. Varying estimates of sepsis mortality using death certificates and administrative codes ” United States, 1999–2014. In weekly, 2016; 65(13): 342-45.
Subandrio A. Studi kasus sepsis di Rumah Sakit Hasan Sadikin, 1996; 3-10.
Subroto YW, Loehoeri S. Profil pasien yang didiagnosis dengan sepsis di bangsal penyakit dalam RS Dr.Sardjito tahun 2002. Berkala Ilmu Kedokteran, 2003; 35: 4.
Jager CPC, van Wijk PTL, Mathoera RB, Leuvenink JJ, Poll T van der, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infections markers in an emergency care unit. Crit Care, 2010; 14(5): 2-8.
Su L, Han B, Liu C, Liang L. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: A prospective cohort study. BMC Infectious Diseases, 2012; 12(157): 1-10.
Du B, Pan J, Chen D, Li Y. Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and noninfectious origin. Chin Med J, 2003; 116(4): 538–42.
Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, Riou B. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: A prospective study. Clinical Infectious Diseases, 2002; 34(7): 895–901.
Jilma B, Blann A, Pernerstorfer T. Regulation of adhesion molecules during human endotoxemia. Am J Respir Crit Care Med, 1999; 159(3): 857-63.
Okashah AS, El-Sawy MM, Beshay BN, Abd El-Raouf A. Ratio of neutrophil to lymphocyte counts as a simple marker for sepsis and severe sepsis in intensive care unit. Research and Opinion in Anesthesia & Intensive Care, 2014; 2: 1-7.
Xia Y, Guo XG, Xing Ji T, Chen Q. Neutrophil count to lymphocyte count ratio is a potential diagnostic index for bacteremia in adult. Life Science Journal, 2014; 11(1): 1-6.
Ljungström LL, Karlsson D, Pernestig A, Andersson R, Jacobsson G. Neutrophil to lymphocyte count ratio performs better than procalcitonin as a biomarker for bacteremia and severe sepsis in the emergency department. Crit Care, 2015; 19(1): 66.
Guidet E, Maury E. Sex and severe sepsis. Crit Care, 2013; 17(3): 144.
Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in Intensive care unit in England, Wales, and Northern Ireland. Crit Care Med, 2003; 31(9): 2332-8.
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. Eng J Med, 2003; 348(16): 1546-54.
The EPISEPSIS Group. EPISEPSI a reappraisal of the epidemiology and outcome of severe sepsis in French Intensive Care Unit. Intensive Care Med, 2004; 30(4): 580-8.
Starr ME, Saito H. Sepsis in old age: Review of human and animal studies. Aging and Diseases, 2014; 5(2): 126-36.
Goyette RE, Key NS, Ely EW. Hematology changes in sepsis and their therapeutic implication. In: Seminar in Respiratory and Crit Care Med, 2004; 25(6): 45-66.
Filho JCA, Spiller F, Cunha FQ. Neutrophil paralysis in sepsis. In Shock. 2010; 34(1): 15-21.
Marshall JC. Neutrophil in the pathogenesis of sepsis. Crit Care Canada Forum, 2012; 1-5.
Holub M, Beran O, Kasprikova N, Chalupa P. Neutrophil to lymphocyte count ratio as a biomarker of bacterial infection, 2012, 7(2): 258-61.
Loonen AJM, Jager CPC, Tosserans J, Kusters R, Hilbink M, Wever PC, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnosis in an emergency care unit. Bloodstream Infection Diagnostics, 2014; 9(1): 1-7.
Meisner M. Primary indications. In procalcitonin-biochemistry and clinical diagnosis. 1st Ed., London, UNI-MED Verlag AG Breman, 2010; 17-30.
Meynaar IA, Droog W, Batstra M, Vreede R, & Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Research and Practice, 2011; 2011: 1-7.
Nurdani A. Korelasi rasio neutrofil limfosit dengan kadar prokalsitonin pada pasien sepsis. Surabaya, Fakultas Kedokteran Universitas Airlangga, 2016; 61-5.
Silalahi B. Hubungan antara neutrophil lymphocyte count rasio dengan kadar prokalsitonin pada pasien sepsis di ICU RSU Adam Malik. Sumatera Utara, Fakultas Kedokteran Universitas Sumatera Utara, 2015; 38.
Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratis Lek Listy (PubMed), 2001; 102(1): 5-14.
Pugin J, Meisner M, Leon A, Gendrel D, Lopez AF. Guide for the clinical use of Procalcitonin (PCT). In diagnosis and monitoring of sepsis. 7th Ed., BRAHMS, 2008; 1-24.
